Literature DB >> 16900651

[Current opinions in therapeutics of advanced laryngeal carcinoma].

Yue-Huang Wu1, Ping-Zhang Tang.   

Abstract

The treatment of advanced laryngeal cancer constitutes a constant challenge to surgeons. Although various therapeutic modalities have been employed in the past century, the cure rate remains unsatisfactory. Current opinions in the therapeutics of this disease pay more attention to the preservation of larynx function and the improvement of quality of life. It is practical to improve the survival rate and quality of life by upgrading the conservative surgical techniques and radiotherapy tactics, neo-adjuvant therapies, and especially the combined treatment using concurrent chemoradiotherapy.

Entities:  

Mesh:

Year:  2006        PMID: 16900651

Source DB:  PubMed          Journal:  Zhongguo Yi Xue Ke Xue Yuan Xue Bao        ISSN: 1000-503X


  3 in total

1.  Contribution of TIP30 to chemoresistance in laryngeal carcinoma.

Authors:  M Zhu; F Yin; L Yang; S Chen; R Chen; X Zhou; W Jing; X Fan; R Jia; H Wang; H Zheng; J Zhao; Y Guo
Journal:  Cell Death Dis       Date:  2014-10-16       Impact factor: 8.469

2.  Combining use of Phillyrin and autophagy blocker alleviates laryngeal squamous cell carcinoma via AMPK/mTOR/p70S6K signaling.

Authors:  Da-Hua Wang; Xi He; Qing He
Journal:  Biosci Rep       Date:  2019-06-20       Impact factor: 3.840

3.  TIMP-3 Increases the Chemosensitivity of Laryngeal Carcinoma to Cisplatin via Facilitating Mitochondria-Dependent Apoptosis.

Authors:  Xiaohui Shen; Xia Gao; Hui Li; Yajun Gu; Junguo Wang
Journal:  Oncol Res       Date:  2018-03-09       Impact factor: 5.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.